Drug
Empagliflozin/Linagliptin clinical trials
How studies write it
Studies that test it under each name
Name
- Glyxambi film-coated tablets
- 2
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Humanis Saglık Anonim Sirketi (2) · Institut für Pharmakologie und Präventive Medizin (1)
Often tested with
Tested in the same studies.
Empagliflozin (1) · Linagliptin (1) · Metformin (1) · Insulin (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Empagliflozin/Linagliptin is read from its arms, and is right about nine times in ten.
Testing it · 3
- To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.CompletedPhase 1Humanis Saglık Anonim SirketiNCT07039890Written as Glyxambi film-coated tablets
- Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated TabletsCompletedPhase 1Humanis Saglık Anonim SirketiNCT06932159Written as Glyxambi film-coated tablets
- Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesCompletedPhase 3Institut für Pharmakologie und Präventive MedizinNCT02752113Written as Empagliflozin and Linagliptin